RRM2 and non-small cell lung carcinoma: Xie et al. evidenced that miR-520a inhibits non-small cell lung cancer (NSCLC) progression through suppression of ribonucleoside-diphosphate reductase subunit M2 (RRM2) and Wnt signaling pathways [21].